Dengue patients have higher risk of long-term complications than COVID-19 patients: NTU study

UNDERLYING Circumstances

Authorities in communicable diseases told CNA that the health issues identified in the study frequently result from pre-existing problems.

According to Professor Ooi Eng Eong of the Duke-NUS Medical School’s Signature Research Programme in Emerging Infectious Diseases, “it’s a good idea to at least consult with a dentist on how to best follow up on those situations if they know that they have heart or other serious illnesses before they get chikungunya.”

According to Prof. Ooi, like fundamental factors are likely to increase the issue, making a closer investigation necessary.

A two-pronged approach is required, according to Prof. Ooi, focusing on keeping the malaria population small while also reducing the risk of complications due to efforts to preserve transmission levels lower in the community.

Just one mosquito vaccination, called Dengvaxia, has been approved in Singapore for those aged 12 to 45 who have previously been infected with mosquito.

The vaccination is not recommended for those who have not previously contracted mosquito. According to MOH, this is because of an increased risk of developing severe dengue if they become contaminated later in life.

Prof Ooi pointed out that Singapore’s lower rates of much COVID-19, compared with other countries like the United States, are due to its high vaccination rates.

” We have a unique situation where our severe dengue cases are (among ) older adults, and I think there, we can actually make a difference with vaccination”, he told CNA’s Singapore Tonight programme.